Showing results (151-160 of 269) with videos related to

Sort By:
Pageof 27
Haematologica|October 19, 2010
A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patientsMaurizio Zangari, Shmuel Yaccoby, Lisa Pappas, et al.
Cancer Research|March 11, 2010
Constitutively active Stat3 enhances neu-mediated migration and metastasis in mammary tumors via upregulation of CtenIsaia Barbieri, Sara Pensa, Tania Pannellini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunityMichela Spadaro, Elena Ambrosino, Manuela Iezzi, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 8, 2011
A DNA vaccine against ERBB2 impairs chemical carcinogenesis in random-bred hamstersGiovanni N Berta, Andrea E Sprio, Manuela Iezzi, et al.
Therapeutic Advances in Medical Oncology|June 21, 2019
Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcomaFederica Riccardo, Lidia Tarone, Selina Iussich, et al.
Veterinary and Comparative Oncology|August 15, 2021
Prognostic impact of bone invasion in canine oral malignant melanoma treated by surgery and anti-CSPG4 vaccination: A retrospective study on 68 cases (2010-2020)Mariateresa Camerino, Davide Giacobino, Luca Manassero, et al.
Oncoimmunology|January 27, 2017
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesisSilvio Bandini, Marco Macagno, Albana Hysi, et al.
The Veterinary Quarterly|March 10, 2025
Clinical evaluation of HuDo-CSPG4 DNA electroporation as adjuvant treatment for canine oral malignant melanoma: comparison of two vaccination protocolsMariateresa Camerino, Davide Giacobino, Lidia Tarone, et al.
The EMBO Journal|May 26, 2007
p140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activityPaola Di Stefano, Laura Damiano, Sara Cabodi, et al.
The American Journal of Pathology|April 30, 2013
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2Maddalena Arigoni, Giuseppina Barutello, Federica Riccardo, et al.
Pageof 27